Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Clinical trial NCT02469857 · COMPLETED
Trial details
- NCT number
- NCT02469857
- Sponsor
- Atox Bio Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-08-18
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.